CUE BIOPHARMA INC. - COMMON STOCK
1.1530
25-November-24 13:10:57
15 minutes delayed
Stocks
+0.1330
+13.04%
Today's range
1.0500 - 1.2431
ISIN
N/A
Source
NASDAQ
-
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
11 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the JMP Securities Life Sciences Conference
13 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Jefferies Healthcare Conference
01 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
26 May 2022 16:00:00 By Nasdaq GlobeNewswire
-
11 May 2022 07:01:12 By Nasdaq GlobeNewswire
-
Cue Biopharma Reports First Quarter 2022 Financial Results
10 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Upcoming Oppenheimer 32nd Annual Healthcare Conference
10 Mar 2022 07:00:02 By Nasdaq GlobeNewswire
-
02 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
15 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials
20 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
05 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer
15 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at JMP Securities Hematology and Oncology Summit
06 Dec 2021 07:00:03 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
10 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
21 Oct 2021 11:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
28 Sep 2021 07:00:02 By Nasdaq GlobeNewswire